Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04805541Completed

Detection and Classification of Diabetic Retinopathy From Posterior Pole Images With A Deep Learning Model

Role: lead

NCT06213896Completed

Detecting Eye Diseases Via Hybrid Deep Learning Algorithms From Fundus Images

Role: lead

NCT05471986Unknown

Multicenter Diagnostic Clinical Performance Study For Automated Detection of Diabetic Retinopathy

Role: lead

All 3 trials loaded